Benchmark analysis of strategies hospitals use to control antimicrobial expenditures

被引:62
作者
Rifenburg, RP
Paladino, JA
Hanson, SC
Tuttle, JA
Schentag, JJ
机构
[1] MILLARD FILLMORE HLTH SYST,CLIN PHARMACOKINET LAB,TECHNOL ASSESSMENT PROGRAM,BUFFALO,NY 14209
[2] SUNY BUFFALO,BUFFALO,NY
[3] MILLARD FILLMORE HLTH SYST,CLIN PHARMACOKINET LAB,SUBURBAN DIV,WILLIAMSVILLE,NY
关键词
administration; antibiotics; benchmarking; control; costs; data collection; drug use; formularies; pharmacy; institutional; hospital; prescribing;
D O I
10.1093/ajhp/53.17.2054
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Hospital expenditures on antimicrobial drugs, antimicrobial management practices, and the effects of these practices were studied. A survey on institutional budget, size, and staffing; intensive care unit drug costs and use evaluations; and pharmacy expenditures, including antimicrobial costs, for 1993 and 1994 was sent to 122 hospitals. The written survey was followed by telephoned questions regarding each institution's antimicrobial management and expenditures, and any perceived link between the two. Hospitals were grouped by size and type, data were normalized to costs per occupied bed and costs per occupied bed per case mix index, and averages for each size category were calculated for general institutional information and expenses per antimicrobial. Eighty-eight institutions (72%) responded. Although 61% to 74% of the respondents used an antimicrobial formulary to restrict drug choices and control costs, average total antimicrobial expenses increased by more than $300 per occupied bed between 1993 and 1994. Only 7% of the institutions saw decreased costs of $500 or more per occupied bed. The most common reasons for these decreases were restructuring of pricing contracts and implementation of educational programs. The replacement of one formulary alternative with another led to increases in the use of antimicrobials other than the replacement drug and often did not produce savings. The replacement of one formulary antimicrobial with another led more to cost-shifting than to overall savings.
引用
收藏
页码:2054 / 2062
页数:9
相关论文
共 18 条
  • [1] BERGMAN R, 1994, HOSP HEALTH NETWORK, V68, P48
  • [2] BERGMAN R, 1994, HOSP HEALTH NETWORK, V68, P50
  • [3] COST OF PHARMACEUTICAL SERVICES IN US HOSPITALS IN 1992
    BOND, CA
    RAEHL, CL
    PITTERLE, ME
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1995, 52 (06) : 603 - 613
  • [4] ANTIBIOTIC STREAMLINING FROM COMBINATION THERAPY TO MONOTHERAPY UTILIZING AN INTERDISCIPLINARY APPROACH
    BRICELAND, LL
    NIGHTINGALE, CH
    QUINTILIANI, R
    COOPER, BW
    SMITH, KS
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1988, 148 (09) : 2019 - 2022
  • [5] CATANIA HF, 1988, HOSP PHARM, V23, P883
  • [6] GOLDFARB MG, 1992, HEALTH SERV RES, V27, P385
  • [7] HYATT JM, IN PRESS J HOSP INFE
  • [8] MCGOWAN JE, 1995, J HOSP INFECT CONTRO, V15, P478
  • [9] CLINICAL AND ECONOMIC-EVALUATION OF ORAL CIPROFLOXACIN AFTER AN ABBREVIATED COURSE OF INTRAVENOUS ANTIBIOTICS
    PALADINO, JA
    SPERRY, HE
    BACKES, JM
    GELBER, JA
    SERRIANNE, DJ
    CUMBO, TJ
    SCHENTAG, JJ
    [J]. AMERICAN JOURNAL OF MEDICINE, 1991, 91 (05) : 462 - 470
  • [10] Patrick M S, 1992, Healthc Forum J, V35, P71